Engaging the private sector to strengthen NCD prevention and control

Allen, Luke; Bloomfield, Ashley

doi:10.1016/s2214-109x(16)30216-9

Cited by 57 publications

(25 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In conclusion, the engagement with the private sector to strengthen prevention and control of NCDs remains crucial and challenging 33,34 . The vision of the IHCI is to improve hypertension control and reduce the associated burden within the next 5 years.…”

Section: Discussionmentioning

confidence: 99%

A perspective of private health care providers in the state of Madhya Pradesh on adopting key strategies of the India hypertension control initiative

Krishna¹,

Pathni²,

Sharma³

et al. 2020

J of Clinical Hypertension

View full text Add to dashboard Cite

The India Hypertension Control Initiative (IHCI) has been implemented in public health facilities. This study assessed the perspective of private physicians (PPs) on adopting the core strategies of the IHCI in Bhopal district of Madhya Pradesh. A semi‐structured interview was purposely applied to 30 PPs to obtain their opinions on standardized hypertension treatment protocols, patient‐centered services, and easy‐to‐use information system in their private practices. Verbatim data were recorded and analyzed thematically. Only 11 PPs followed the state hypertension treatment protocol. Among the remaining 19 PPs, the major reasons for not adopting protocol were (1) limited availability of single component hypertension drugs, (2) preferences for fixed dose combinations (FDCs), and (3) fear of either losing patients due to a lack of immediate blood pressure control or causing drug‐related adverse effects. None of the interviewed doctors had resources to provide patient‐centered care and use a digital health information system. Overall, the interviewed doctors identified that free supply of hypertension treatment protocol drugs, inclusion of FDCs in treatment protocol, increasing number of staff for follow‐up visits, and patient education, IT‐based solutions for patient records, employee incentives, and need for national data sharing policies are the key actions to accelerate the adoption of IHCI strategies in the private sector. This exploratory qualitative study suggests that engagement of private sector in the IHCI is feasible. Plans to expand the IHCI to the private sector should consider ensuring the wider availability of hypertension treatment protocol drugs and developing a simple user‐friendly digital platform for patient monitoring.

show abstract

Section: Discussionmentioning

confidence: 99%

A perspective of private health care providers in the state of Madhya Pradesh on adopting key strategies of the India hypertension control initiative

Krishna¹,

Pathni²,

Sharma³

et al. 2020

J of Clinical Hypertension

View full text Add to dashboard Cite

show abstract

“…For example, working in partnership and collaborating with other sectors such as the private sector will mean prevention researchers must consider appropriate controls around managing conflicts of interest and industry engagement 29-32 . Some have noted this is a confusing and challenging area for public health researchers to navigate outside of tobacco control 33 …”

Section: New Ways Of Thinking For Chronic Disease Preventionmentioning

confidence: 99%

What does the future hold for chronic disease prevention research?

Howse

Rychetnik

Marks

et al. 2020

Australian and New Zealand Journal of Public Health

View full text Add to dashboard Cite

“…The private sector can draw on its business and scientific expertise, focusing on strong results-based operations, whereas the public sector can bring its experience in advancing public health interests and ensuring equity. Governments can also help align private sector incentives with national NCD strategies and plans through the use of taxes, subsidies and reduced compliance costs (15).…”

Section: Broader Engagement With Industry To Address Cvds and Other Ncdsmentioning

confidence: 99%

Interact, engage or partner? Working with the private sector for the prevention and control of noncommunicable diseases

Collins¹,

Mikkelsen²,

Axelrod³

2019

Cardiovasc. Diagn. Ther

View full text Add to dashboard Cite

Noncommunicable diseases (NCDs), including cardiovascular diseases (CVDs), cancers, chronic respiratory diseases and diabetes, account for 72% of all global deaths, with 78% of all NCDs taking place in low-and middle-income countries. Among these four main groups of NCDs, CVDs are taking the highest death toll at 17.9 million or 44% of all NCD mortality. This paper suggests that the complex interplay of NCD risk factors and their underlying social and commercial determinants requires active cooperation with the private sector to bring about policy change, pool resources and generate innovative solutions by capitalizing on each partner's strengths. However, such partnerships can only be successful if safeguards are in place to define the rules of engagement, align incentives to achieve shared public health objectives and manage potential conflicts of interest.

show abstract

Engaging the private sector to strengthen NCD prevention and control

Cited by 57 publications

References 2 publications

A perspective of private health care providers in the state of Madhya Pradesh on adopting key strategies of the India hypertension control initiative

A perspective of private health care providers in the state of Madhya Pradesh on adopting key strategies of the India hypertension control initiative

What does the future hold for chronic disease prevention research?

Interact, engage or partner? Working with the private sector for the prevention and control of noncommunicable diseases

Contact Info

Product

Resources

About